Quantitative assessment of Pasifika rheumatic fever burde

Not Applicable

• Conditions: Rheumatic fever; Inflammatory and Immune System - Autoimmune diseases; Infection - Other infectious diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12622000565741
• Lead Sponsor: Dr Siobhan Tu'akoi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-13
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100000

Inclusion Criteria

All patients enrolled with the following four primary health organisations based in Auckland, New Zealand: Alliance Health Plus, National Hauora Coalition, Pro Care, Tamaki Health, from 31 March 2017 to 1 April 2022.

Exclusion Criteria

Patients not enrolled at one of the four outlined primary health organisations in Auckland.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The annual incidence of rheumatic fever by ethnicity among the Auckland population. Data will be collected via data-linkage to medical records.[ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point.];The annual incidence of rheumatic fever by 5-year age groups among the Auckland population. Data will be collected via data-linkage to medical records.[ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point.];The annual incidence of rheumatic fever by ethnicity among the Auckland population. Data will be collected via data-linkage to medical records.[ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point.]

Secondary Outcome Measures

Name	Time	Method
The proportion of patient throat swabs positive for Group A Streptococcus, and compared by ethnicity. Data will be collected via data-linkage to medical records.[ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point];The proportion of patients hospitalised due to rheumatic fever and rheumatic heart disease. [ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point.];Among patients with rheumatic fever, the proportion who receive ongoing monthly treatment/medication such as penicillin injections.[ Retrospective data will be collected from patient medical record from 31 March 2017 to 1 April 2022 at a single time point.]